<DOC>
	<DOCNO>NCT01598571</DOCNO>
	<brief_summary>Study healthy male assess bioavailability single fostamatinib iv micro tracer dose .</brief_summary>
	<brief_title>Study Healthy Males Assess Bioavailability Single Fostamatinib With iv Micro Tracer Dose</brief_title>
	<detailed_description>A Study Assess Absolute Bioavailability Single Oral Dose Fostamatinib Respect Intravenous Micro Tracer Dose [ 14C ] R406 Healthy Male Volunteers .</detailed_description>
	<criteria>Healthy male volunteer age 18 55 year ( inclusive ) , weight least 50 kg body mass index ( BMI ) 18 30 kg/m2 ( inclusive ) Male volunteer willing use barrier contraception ie , condom spermicide , first day investigational product administration 3 month last administration investigational product History clinically significant disease disorder History presence GI , hepatic , renal disease condition know interfere absorption , distribution , metabolism , excretion drug Any clinically significant illness , medical/surgical procedure trauma within 4 week first administration drug Volunteers smoke 5 cigarette equivalent tobacco per day Any clinically significant abnormality clinical chemistry , hematology urinalysis result judge Investigator</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Healthy male volunteer</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>fostamatinib</keyword>
	<keyword>Bioavailability</keyword>
	<keyword>R406 plasma AUC Cmax</keyword>
	<keyword>R406 plasma AUC0-t</keyword>
	<keyword>t1/2Î»z</keyword>
	<keyword>tmax</keyword>
</DOC>